NFATc2 inhibitors constitute a specialized class of compounds meticulously designed to selectively target and impede the function of Nuclear Factor of Activated T-cells, cytoplasmic 2 (NFATc2). As a transcription factor, NFATc2 holds a pivotal position in orchestrating gene expression cascades, particularly within immune cells. It is an integral member of the NFAT transcription factor family, intricately involved in the modulation of immune responses, cellular differentiation, and diverse cellular processes vital for homeostasis. The modus operandi of NFATc2 inhibitors centers around the precise targeting of the NFATc2 protein, a strategic approach aimed at disrupting its intracellular dynamics. Specifically, these inhibitors have the ability to impede the translocation of NFATc2 from the cytoplasm to the nucleus-a requisite step for the exertion of its transcriptional activities. By obstructing this pivotal translocation process, NFATc2 inhibitors exert a nuanced influence on the expression patterns of genes under the purview of NFATc2. This modulation extends beyond immune responses, impacting various cellular functions governed by NFATc2-mediated transcriptional programs.
Ongoing research endeavors delve into the intricate mechanisms that underlie the functionality of NFATc2 inhibitors, seeking to elucidate their exact modes of action. This exploration not only contributes to advancing our comprehension of the molecular intricacies governing gene expression but also holds promise for unveiling the broader implications of NFATc2 inhibition in deciphering immune regulation and cellular responses. The study of NFATc2 inhibitors, therefore, emerges as a scientific frontier, offering insights that extend beyond the specific protein target, transcending into a deeper understanding of the intricate dance between transcription factors and the dynamic orchestration of immune system dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits the phosphatase activity of calcineurin, preventing NFATc2 dephosphorylation. This inhibits NFATc2 nuclear translocation and its downstream effects on immune responses. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Similar to Cyclosporin A, FK506 binds to FKBP12 and inhibits calcineurin. This leads to the suppression of NFATc2 activation and its transcriptional activity. | ||||||
NFAT Activation Inhibitor III | 3519-82-2 | sc-203160 | 10 mg | $117.00 | 2 | |
INCA-6 is a small molecule inhibitor that specifically targets NFATc2. It disrupts the interaction between NFATc2 and its transcriptional co-activator, preventing NFATc2-mediated gene transcription. | ||||||